Results 161 to 170 of about 3,913,962 (299)

Questions in Healthcare Specifically Related to the Discipline of Pharmacy: A Descriptive Analysis of Queries to Drug Information Centres in Sweden. [PDF]

Basic Clin Pharmacol Toxicol
Asker F, Gimerus S, Parodi López N, Wallerstedt SM.   +3 more
europepmc   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Sistema Brasileiro de Informação sobre Medicamentos - SISMED

Cadernos de Saúde Pública
Foram descritas as atividades do farmacêutico especialista em informação sobre medicamentos (IM) e caracterizados os Centros de Informação sobre Medicamentos (CIMs), deixando claro o que não são e o que são - mitos e fatos.
Carlos C. F. Vidotti, Rogério Hoefler, Emília Vitória Silva, Gun Bergsten-Mendes   +3 more
doaj  

Effectiveness of ChatGPT, Google Gemini, and Microsoft Copilot in Answering Thai Drug Information Queries: Cross-Sectional Study. [PDF]

JMIR AI
Pornwattanakavee S, Leelakanok N, Todsarot T, Guinto GAT, Takun R, Sumativit A, Senngam M.   +6 more
europepmc   +1 more source

Explosive drug information in the time of COVID-19. [PDF]

Can Pharm J (Ott), 2021
Schulz M, Schumacher PM, Schneider J, Said A, Laufs U.   +4 more
europepmc   +1 more source

Government publications – resources on drug information [PDF]

, 1977
Whitlatch, Jo Bell
core   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

A Critical Juncture for Drug Information and Evidence-Based Voices. [PDF]

J Pediatr Pharmacol Ther
Kier K.
europepmc   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Design and development of a mobile application for drug information and other health data for users and patients of pharmacies and outpatient pharmaceutical services. [PDF]

Explor Res Clin Soc Pharm
Agudelo R, Granados J, Ceballos M, Pereañez JA.   +3 more
europepmc   +1 more source